NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	01/08/2017
Target sample size	33
Countries of recruitment	Asia except Japan,North America,Europe,Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : concizumab Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	safety

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Male
Include criteria
Exclude criteria